lorecivivint
not tagged
[]
 lorecivivint is a wnt pathway inhibitor prior phase 2 trial data: #acr22
@bu_bmc_rheum | @rheum_covid @spartan_updates @official_asas | @UWRheum @UWEpidemiology 2020 | @OHSUIMres 2017 | @UTMBhealth 2014 | @UTAustin 2010